Central Nervous System Neuropathy

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Neuropathy Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Neuropathy Projects
--Chiesi Farmaceutici S.p.A
--Anesiva, Inc.
--Eisai Co Ltd
--DARA BioSciences, Inc.
--GlaxoSmithKline plc
--Eli Lilly & Co
--King Pharmaceuticals Inc
--Glenmark Pharmaceuticals Limited
--Nycomed
--Nutra Pharma Corp
--Pfizer Inc
--Otsuka Pharmaceutical Co., Ltd.
--ReceptoPharm, Inc
--Pierre Fabre Medicament
--Santhera Pharmaceuticals AG
--Sanochemia Pharmazeutika AG
--Talecris Biotherapeutics
--Shionogi & Co., Ltd.
--Vernalis Plc ADR
--UCB S.A.

--Top Companies in early stage Neuropathy Projects
--Allon Therapeutics Inc.
--Aegera Therapeutics Inc.
--Cara Therapeutics Inc
--Argolyn Bioscience Inc.
--Krenitsky Pharmaceuticals Inc.
--Daewoong Pharmaceutical Co. Ltd.
--Neuren Pharmaceuticals Limited
--Metabolic Pharmaceuticals Ltd.
--Neuromed Pharmaceuticals Ltd.
--erly NeuroMed Technologies)
--NeuroDiscovery Ltd
--NsGene A/S
--Novasite Pharmaceuticals, Inc.
--PharmAust Limited
--Nyxis Neurotherapies, Inc.
--SK Bio-Pharmaceuticals
--Roxro Pharma Inc.
--TheraQuest Biosciences
--Sosei Group Corporation
--VistaGen Therapeutics, Inc.
--Trophos SA

Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View